Onconova Therapeutics Company Profile (NASDAQ:ONTX)

About Onconova Therapeutics

Onconova Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company operates through the identification and development of oncology therapeutics segment. It is focused on discovering and developing small molecule drug candidates to treat cancer. The Company has created a targeted anti-cancer agents designed to work against specific cellular pathways that are important to cancer cells. It has over three clinical-stage product candidates and various preclinical programs that target kinases, cellular metabolism or cell division in preclinical development. The Company's lead product candidate, rigosertib, is being tested in both intravenous (IV) and oral formulations as a single agent, and the oral formulation is also being tested in combination with azacitidine, in clinical trials for patients with myelodysplastic syndromes (MDS), and related cancers. Its other product candidates include Briciclib and Recilisib.

Industry, Sector and Symbol:

Sector: Medical
Industry: Biotechnology
Sub-Industry: N/A
Exchange: NASDAQ
Symbol: ONTX
CUSIP:

Key Metrics:

Previous Close: $3.10
50 Day Moving Average: $3.24
200 Day Moving Average: $4.48
52-Week Range: $6,340,000.00 - $2.62
Trailing P/E Ratio: N/A
Foreward P/E Ratio: -1.07
P/E Growth: 0.00
Market Cap: $19.65M
Outstanding Shares: 6,340,000
Beta: -0.19

Profitability:

Net Margins: -102.42%
Return on Equity: -256.32%
Return on Assets: -71.81%

Debt:

Current Ratio: 1.76%
Quick Ratio: 1.76%

Additional Links:

Companies Related to Onconova Therapeutics:

Consensus Ratings for Onconova Therapeutics (NASDAQ:ONTX) (?)

Ratings Breakdown:	3 Buy Ratings
Consensus Rating:	Buy (Score: 3.00)
Consensus Price Target:	$33.67 (986.02% upside)

Analysts' Ratings History for Onconova Therapeutics (NASDAQ:ONTX)

Show:

Date	Firm	Action	Rating	Price Target
8/19/2016	Maxim Group	Reiterated Rating	Buy	$6.00
3/29/2016	HC Wainwright	Reiterated Rating	Buy
12/9/2015	Piper Jaffray Cos.	Reiterated Rating	Overweight	$60.00
8/28/2015	Janney Montgomery Scott	Reiterated Rating	Neutral -> Fair Value	$30.00 -> $15.20
2/3/2015	Leerink Swann	Downgrade	Outperform -> Market Perform

(Data available from 9/26/2014 forward)

Earnings History for Onconova Therapeutics (NASDAQ:ONTX)

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
11/9/2016
8/15/2016	Q2		($1.96)		$2.25 million	View	N/A
5/12/2016	Q1	($0.19)	($0.27)			View	N/A
3/28/2016	Q4	($0.27)	$0.18			View	N/A
11/11/2015	Q3	($0.32)	($0.26)			View	N/A
8/13/2015	Q2	($0.56)	($0.41)			View	N/A
5/14/2015	Q1	($0.63)	($0.57)			View	N/A
3/26/2015		($0.71)	($0.62)			View	N/A
11/13/2014		($0.78)	($0.69)			View	N/A
8/13/2014		($0.89)	($0.77)			View	N/A
5/12/2014		($0.78)	($0.87)			View	N/A
3/10/2014	Q4 13	($1.07)	($0.68)	$1.07 million	$1.93 million	View	N/A
11/12/2013	Q3	($0.66)	($1.34)	$1.07 million	$1.12 million	View	Listen
9/6/2013	Q213		($5.21)	$0.22 million	$0.59 million	View	N/A

(Data available from 1/1/2011 forward)

Earnings Estimates for Onconova Therapeutics (NASDAQ:ONTX)

Current Year EPS Consensus Estimate: $-2.15 EPS
Next Year EPS Consensus Estimate: $-2.91 EPS

Dividend History for Onconova Therapeutics (NASDAQ:ONTX)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Onconova Therapeutics (NASDAQ:ONTX)

Insider Ownership Percentage: 27.30%
Institutional Ownership Percentage: 2.36%

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
2/21/2014	& Jane Hoffman 2013 De Michael	major shareholder	Buy	143,480	$8.47	$1,215,275.60
2/10/2014	Ramesh Kumar	CEO	Sell	33,543	$15.07	$505,493.01
2/3/2014	Ramesh Kumar	CEO	Sell	60,000	$15.05	$903,000.00
1/27/2014	Michael Hoffman	Director	Buy	57,295	$11.92	$682,956.40
11/22/2013	Michael Hoffman	Director	Buy	5,000	$14.39	$71,950.00
11/18/2013	E Premkumar Reddy	Director	Buy	5,000	$12.10	$60,500.00
11/15/2013	& Jane Hoffman 2013 De Michael	major shareholder	Buy	19,700	$11.99	$236,203.00
11/15/2013	Henry Bienen	Director	Buy	1,400	$12.17	$17,038.00
11/15/2013	Ramesh Kumar	CEO	Buy	1,100	$12.02	$13,222.00
7/30/2013	& Jane Hoffman 2013 De Michael	Major Shareholder	Buy	1,000,000	$15.00	$15,000,000.00
7/30/2013	Ramesh Kumar	CEO	Buy	6,667	$15.00	$100,005.00
7/30/2013	Thomas J Mckearn	Insider	Buy	3,333	$15.00	$49,995.00
7/30/2013	Viren Mehta	Director	Buy	16,667	$15.00	$250,005.00
7/25/2013	E Premkumar Reddy	Director	Buy	1,000	$22.72	$22,720.00

(Data available from 1/1/2013 forward)

Latest Headlines for Onconova Therapeutics (NASDAQ:ONTX)

Date	Headline
	Shares Of Onconova Therapeutics, Inc. (NASDAQ:ONTX) Expected To Hit $6 - Investor Newswire (NASDAQ:ONTX) www.investornewswire.com - September 23 at 11:20 AM
	Under the Microscope, Zeroing in at Onconova Therapeutics, Inc. (NASDAQ:ONTX) - Duncan Research (NASDAQ:ONTX) www.duncanindependent.com - September 22 at 6:17 PM
	Penny Stock Investors Take an Interest in Onconova Therapeutics, Inc. (NASDAQ:ONTX) - Duncan Research (NASDAQ:ONTX) www.duncanindependent.com - September 21 at 6:12 PM
	What's in Onconova Therapeutics Inc After Reaching All-Time Low? - Chester News (NASDAQ:ONTX) www.chesterindependent.com - September 16 at 10:07 AM
	How Analysts Feel About Onconova Therapeutics Inc After Reaching 52-Week Low? - Chester News (NASDAQ:ONTX) www.chesterindependent.com - September 14 at 6:42 PM
	Onconova Therapeutics, Inc. to Present Corporate Updates at Upcoming Investor Conferences (NASDAQ:ONTX) www.publicnow.com - September 7 at 10:09 AM
	Can Shares Of Onconova Therapeutics, Inc. (NASDAQ:ONTX) Get To $6? - Investor Newswire (NASDAQ:ONTX) www.investornewswire.com - September 1 at 6:34 PM
	Shares Dropping Lower in Session: Onconova Therapeutics, Inc. (NASDAQ:ONTX) - Post News (NASDAQ:ONTX) www.kentuckypostnews.com - September 1 at 6:34 PM
	Onconova Quietly Terminates 21% of Workforce (NASDAQ:ONTX) www.biospace.com - September 1 at 9:46 AM
	Onconova Therapeutics (ONTX) Announces Job Cuts, Appoints New CFO - StreetInsider.com (NASDAQ:ONTX) www.streetinsider.com - August 31 at 11:38 AM
	More job cuts at Bucks County biopharm firm (NASDAQ:ONTX) www.bizjournals.com - August 31 at 11:38 AM
	Onconova Therapeutics (ONTX) Announces Job Cuts, Appoints New CFO (NASDAQ:ONTX) www.streetinsider.com - August 30 at 6:34 PM
	ETF’s with exposure to Onconova Therapeutics, Inc. : August 30, 2016 (NASDAQ:ONTX) www.capitalcube.com - August 30 at 6:34 PM
	ONCONOVA THERAPEUTICS, INC. Files SEC form 8-K, Costs Associated with Exit or Disposal Activities, Change in Director (NASDAQ:ONTX) biz.yahoo.com - August 30 at 6:34 PM
	Onconova Therapeutics, Inc. (NASDAQ:ONTX) Gets 0 Recommendations To Sell - Investor Newswire (NASDAQ:ONTX) www.investornewswire.com - August 25 at 6:39 PM
	Stock Moving Up in Session: Onconova Therapeutics, Inc. (NASDAQ:ONTX) - Post News (NASDAQ:ONTX) www.kentuckypostnews.com - August 22 at 6:38 PM
	Onconova Therapeutics Inc. (NASDAQ: ONTX) Buy Rating Reiterated at Maxim Group - BNB Daily (blog) (NASDAQ:ONTX) www.baseball-news-blog.com - August 22 at 6:38 PM
	Onconova Therapeutics, Inc.'s (ONTX): Stock Alert - Hot Stocks Point (NASDAQ:ONTX) www.hotstockspoint.com - August 19 at 6:35 PM
	Will Onconova Therapeutics, Inc. (NASDAQ:ONTX) Hit $6 Price Target? - Investor Newswire (NASDAQ:ONTX) www.investornewswire.com - August 19 at 6:35 PM
	Onconova Therapeutics Inc (NASDAQ:ONTX) Looks Risky - Street Register (NASDAQ:ONTX) streetregister.com - August 19 at 6:35 PM
	ETF’s with exposure to Onconova Therapeutics, Inc. : August 19, 2016 (NASDAQ:ONTX) www.capitalcube.com - August 19 at 6:35 PM
	Onconova Therapeutics Inc (NASDAQ:ONTX) Looks Risky (NASDAQ:ONTX) streetregister.com - August 18 at 9:43 AM
	My Watchlist for Thursday, August 18 (NASDAQ:ONTX) ac-investor.blogspot.com - August 17 at 6:56 PM
	New Market Research Report: Onconova Therapeutics, Inc. (ONTX) - Financial and Strategic SWOT Analysis Review (NASDAQ:ONTX) www.live-pr.com - August 16 at 6:48 PM
	Onconova Therapeutics, Inc. Reports Recent Business Highlights and Second Quarter 2016 Financial Results (NASDAQ:ONTX) www.nasdaq.com - August 15 at 6:58 PM
	ONCONOVA THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements a (NASDAQ:ONTX) biz.yahoo.com - August 15 at 6:58 PM
	Onconova Therapeutics, Inc. Announces Timing for Second Quarter 2016 Financial Results (NASDAQ:ONTX) finance.yahoo.com - August 11 at 9:53 AM
	ONCONOVA THERAPEUTICS, INC. Financials (NASDAQ:ONTX) finance.yahoo.com - August 5 at 6:51 PM
	Bucks County biopharm firm closes $17.4M rights offering (NASDAQ:ONTX) www.bizjournals.com - August 1 at 6:25 PM
	Onconova Closes Oversubscribed Rights Offering with Gross Proceeds of $17.4 Million (NASDAQ:ONTX) www.publicnow.com - August 1 at 8:11 AM
	Onconova Announces Expiration of Oversubscribed Rights Offering - GlobeNewswire (press release) (NASDAQ:ONTX) www.globenewswire.com - July 29 at 9:42 AM
	Onconova (ONTX), XBiotech (XBIT), Chembio (CEMI) Lead Most Active on Decline (NASDAQ:ONTX) www.fxpips.com - July 27 at 9:42 AM
	Onconova Announces Expiration of Oversubscribed Rights Offering (NASDAQ:ONTX) www.publicnow.com - July 27 at 9:38 AM
	Onconova Adjusts Pricing of Rights Offering - GlobeNewswire (press release) (NASDAQ:ONTX) globenewswire.com - July 22 at 6:31 PM
	Onconova Therapeutics Incorporated (NASDAQ:ONTX) Sellers ... - Consumer Eagle (NASDAQ:ONTX) www.consumereagle.com - July 22 at 6:31 PM
	Onconova Adjusts Pricing of Rights Offering (NASDAQ:ONTX) www.publicnow.com - July 22 at 6:08 PM
	Onconova Announces Enrollment of First Patient in Japan by SymBio - Nasdaq (NASDAQ:ONTX) www.nasdaq.com - July 20 at 7:26 PM
	New Broker Ratings For Onconova Therapeutics, Inc. (ONTX) - FTSE News (NASDAQ:ONTX) www.ftsenews.co.uk - July 20 at 7:26 PM
	Onconova Announces Enrollment of First Patient in Japan by SymBio - GlobeNewswire (press release) (NASDAQ:ONTX) www.globenewswire.com - July 19 at 8:01 AM
	Onconova Announces Enrollment of First Patient in Japan by SymBio (NASDAQ:ONTX) finance.yahoo.com - July 19 at 7:01 AM
	Onconova Therapeutics Incorporated (NASDAQ:ONTX) Sellers Increased By 163.07% Their Shorts - Consumer Eagle (NASDAQ:ONTX) www.consumereagle.com - July 18 at 12:03 PM
	Institutional Investor Sentiment About Onconova Therapeutics Inc (NASDAQ:ONTX) Up - Consumer Eagle (NASDAQ:ONTX) www.consumereagle.com - July 15 at 11:41 AM
	It Seems Onconova Therapeutics Inc Will Go Down. Formed A Few Months Multiple Bottom Pattern - Consumer Eagle (NASDAQ:ONTX) www.consumereagle.com - July 13 at 6:59 PM
	ONCONOVA THERAPEUTICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and (NASDAQ:ONTX) biz.yahoo.com - July 13 at 4:53 PM
	Onconova Therapeutics, Inc. (ONTX) Updated Price Targets - FTSE News (NASDAQ:ONTX) www.ftsenews.co.uk - July 12 at 6:54 PM
	Today's Watch List: Onconova Therapeutics, Inc. (NASDAQ:ONTX), PDL BioPharma, Inc. (NASDAQ:PDLI), CompX ... - KC Register (NASDAQ:ONTX) www.kcregister.com - July 11 at 6:40 PM
	Onconova Therapeutics Incorporated (NASDAQ:ONTX) Sellers Increased By 163.07% Their Shorts - Press Telegraph (NASDAQ:ONTX) presstelegraph.com - July 8 at 6:42 PM
	Increased Volatility on Shares of: Onconova Therapeutics, Inc. (NASDAQ:ONTX) - Engelwood Daily (NASDAQ:ONTX) www.engelwooddaily.com - July 8 at 6:42 PM
	Onconova Therapeutics, Inc. (ONTX) Current Analyst Ratings - Fiscal Standard (NASDAQ:ONTX) www.fiscalstandard.com - July 8 at 6:42 PM
	Onconova Announces Commencement of Subscription Period for Previously Announced Rights Offering (NASDAQ:ONTX) finance.yahoo.com - July 8 at 9:20 AM